305 related articles for article (PubMed ID: 19940748)
21. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
Walluks K; Chen Y; Woelfel C; Yang L; Cui T; Seliger C; Geier C; Knösel T; Hauke S; Petersen I
Pathol Res Pract; 2013 Jan; 209(1):30-5. PubMed ID: 23207290
[TBL] [Abstract][Full Text] [Related]
22. A novel COL1A1 exon 14/PDGFB fusion gene in dermatofibrosarcoma protuberans.
Muchemwa FC; Jinnin M; Wakasugi S; Sakamoto M; Inoue Y; Ishihara T; Ihn H
Eur J Dermatol; 2010; 20(3):390-1. PubMed ID: 20133221
[No Abstract] [Full Text] [Related]
23. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
[TBL] [Abstract][Full Text] [Related]
24. [Detection of COL1A1/PDGFB fusion transcripts in dermatofibroscoma protuberans by revers transcriptase-polymerase chain reaction using paraffin-embedded tissues].
Yang JH; Hu WH; Li F; Lu TC; Li HA; Chang B; Zhang XB; Zhou XM; Dang HW
Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):409-12. PubMed ID: 14633450
[TBL] [Abstract][Full Text] [Related]
25. Pseudocystic dermatofibrosarcoma protuberans: report of two cases and demonstration of COL1A1-PDGFB rearrangement.
Shvartsbeyn M; Lazar AJ; Lopez-Terrada D; Meehan SA
J Cutan Pathol; 2012 Mar; 39(3):356-60. PubMed ID: 22335595
[TBL] [Abstract][Full Text] [Related]
26. PDGFB quantification is a useful tool in the diagnosis of dermatofibrosarcoma protuberans: a study of 10 cases.
Muchemwa FC; Wakasugi S; Honda Y; Ihn H
Clin Exp Dermatol; 2010 Apr; 35(3):295-9. PubMed ID: 19663837
[TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR.
Gökden N; Dehner LP; Zhu X; Pfeifer JD
J Cutan Pathol; 2003 Mar; 30(3):190-5. PubMed ID: 12641779
[TBL] [Abstract][Full Text] [Related]
28. A rapid and efficient newly established method to detect COL1A1-PDGFB gene fusion in dermatofibrosarcoma protuberans.
Yokoyama Y; Shimizu A; Okada E; Ishikawa O; Motegi S
Biochem Biophys Res Commun; 2012 Aug; 425(2):353-6. PubMed ID: 22842571
[TBL] [Abstract][Full Text] [Related]
29. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
30. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
Bianchini L; Maire G; Pedeutour F;
Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
[TBL] [Abstract][Full Text] [Related]
31. Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS.
Saeki H; Hoashi T; Tada Y; Ashida R; Kuwano Y; Le Pavoux A; Tsunemi Y; Shikada J; Torii H; Kawabata Y; Kikuchi K; Tamada Y; Matsumoto Y; Tamaki K
J Dermatol Sci; 2003 Dec; 33(3):161-7. PubMed ID: 14643521
[TBL] [Abstract][Full Text] [Related]
32. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.
Sirvent N; Maire G; Pedeutour F
Genes Chromosomes Cancer; 2003 May; 37(1):1-19. PubMed ID: 12661001
[TBL] [Abstract][Full Text] [Related]
33. Dermatofibrosarcoma protuberans with COL1A1 (exon 18) -PDGFB (exon 2) fusion transcript.
Saeki H; Ohmatsu H; Hoashi T; Asano N; Idezuki T; Kawabata Y; Asahina A; Kikuchi K; Tamaki K
Br J Dermatol; 2003 May; 148(5):1028-31. PubMed ID: 12786837
[TBL] [Abstract][Full Text] [Related]
34. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
35. Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement.
Makino M; Sasaoka S; Nakanishi G; Makino E; Fujimoto W
Diagn Pathol; 2016 Mar; 11():24. PubMed ID: 26932148
[TBL] [Abstract][Full Text] [Related]
36. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
37. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
38. Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans.
Zhu R; Yan J; Li B; Tan F; Yan W; Shen J; Fan L; Ding L; Chen Y; Tang Y; Liu Y; Bai Y
Exp Mol Pathol; 2021 Oct; 122():104672. PubMed ID: 34371012
[TBL] [Abstract][Full Text] [Related]
39. Angiomatoid features in fibrohistiocytic sarcomas. Immunohistochemical, ultrastructural, and clinical distinction from vascular neoplasms.
Costa MJ; McGlothlen L; Pierce M; Munn R; Vogt PJ
Arch Pathol Lab Med; 1995 Nov; 119(11):1065-71. PubMed ID: 7487409
[TBL] [Abstract][Full Text] [Related]
40. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans.
Maire G; Fraitag S; Galmiche L; Keslair F; Ebran N; Terrier-Lacombe MJ; de Prost Y; Pedeutour F
Arch Dermatol; 2007 Feb; 143(2):203-10. PubMed ID: 17310000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
